Intech Biopharm Corporation (TPEX:6461)
Taiwan · Delayed Price · Currency is TWD 15.35
+0.05 (0.33%)
Jun 18, 2026, 1:24 PM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 2.74 billion as of June 18, 2026. Its market cap has increased by 5.60% in one year.
Market Cap
2.74B
Enterprise Value
3.54B
Revenue
117.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.35
Market Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 2.74B, a decrease of -31.61%. That is a compound annual growth rate of -3.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.74B | -5.57% |
| Dec 31, 2025 | 2.90B | -20.37% |
| Dec 31, 2024 | 3.64B | -11.36% |
| Dec 29, 2023 | 4.11B | 5.65% |
| Dec 30, 2022 | 3.89B | 67.22% |
| Dec 30, 2021 | 2.33B | 11.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SYN-TECH Chem. & Pharm. | 3.23B |
| Energenesis Biomedical CO.,LTD. | 3.22B |
| Shine-On BioMedical | 3.15B |
| BioGend Therapeutics | 3.10B |
| BRIM Biotechnology | 2.98B |
| Apex Biotechnology | 2.93B |
| Genovate Biotechnology | 2.92B |
| GlycoNex Incorporation | 2.85B |